Authors
Latest:
COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and PharmacotherapyExamining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
Latest:
Getting Help from HAL: Applying Machine Learning to Predict Antibiotic ResistanceA pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Latest:
Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.
Latest:
Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health SystemsAs the first line of acute care, emergency departments are key stewards of antibiotics.
Latest:
Real-World Effectiveness of Cefiderocol in Treating Serious Gram-Negative Infections: Insights from the PROVE StudyCornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.
Latest:
Sorry Ganciclovir, You’re Just Not the One for MeImportant clinical considerations to know about resistant CMV infections.
Latest:
Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health SystemsAs the first line of acute care, emergency departments are key stewards of antibiotics.
Latest:
To Prophylax or not to Prophylax: Preventing CDIClinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
Latest:
STAY PrEPARED: Understanding COVID-19 Pre-Exposure ProphylaxisNew therapeutics offer some hope in this emerging market.
Latest:
Top 5 Tips for Teaching ID LearnersThe latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
Latest:
Combination Antifungal for Invasive Mucormycosis: Yay or Nay?There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Latest:
Mixed Fungal Brain AbscessClinicians review a patient case including diagnosis, treatment, and follow-up.
Latest:
NAFLD Is Increasingly Affecting Patients With HIVThe prevalence of this disease in this patient population is much higher than in the general public.
Latest:
SPREADing the Love: The Importance of Mentorship in PharmacyIn the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
Latest:
The Role of Pharmacists in the World of Pediatric Antimicrobial StewardshipThe limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Influenza Vaccination With SARS-CoV-2 mRNA Booster ShotsDrs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
Latest:
Reducing Vaccine Hesitancy: A Key is Trust Between Patient and ProviderResearch presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.
Latest:
What We Know But Still Have to Learn About Long COVIDDespite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.
Latest:
Exploring the Recently Approved and Upcoming Clostridioides difficile TherapeuticsThis market has seen a flurry of activity, as shown by a review of the latest agents.
Latest:
COVID-19 Convalescent Plasma: What Is Its Role in Therapy?The key is using the right dose on the right patient at the right time.
Latest:
INSTIs and Cardiovascular Outcomes: More ComplexityThe significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.
Latest:
Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) BacteremiaEmerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).
Latest:
A Review of the Currently Available Monoclonal Antibodies for COVID-19Outside of vaccines, these underutilized therapies are the best defense against severe disease.
Latest:
Vancomycin AUC Implementation in Resource-Limited Settings and its Associated DifficultiesThe latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.
Latest:
Fever of Unknown Origin: What Do We Know and Where Do We Go?As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
Latest:
Opposing Forces During COVID-19: Perspective From the ICUConflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
